Iranian Red Crescent Medical Journal

Published by: Kowsar

Comparison of Serum Levels of Procalcitonin and C-Reactive Protein in Patients with Community Acquired Pneumonia and COPD Exacerbation

Ali Taghizadieh 1 , Hassan Soleimanpour 2 , Farzad Rahmani 3 , * , Kavous Shahsavari Nia 3 and Hossein Khodaverdizadeh 4
Authors Information
1 Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
2 Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
3 Road Traffic Injury Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
4 Student's Research Committee, Tabriz University of Medical Sciences, Tabriz, IR Iran
Article information
  • Iranian Red Crescent Medical Journal: December 01, 2016, 18 (12); e25811
  • Published Online: August 7, 2016
  • Article Type: Research Article
  • Received: December 9, 2014
  • Revised: June 27, 2015
  • Accepted: July 22, 2015
  • DOI: 10.5812/ircmj.25811

To Cite: Taghizadieh A, Soleimanpour H, Rahmani F, Shahsavari Nia K, Khodaverdizadeh H. Comparison of Serum Levels of Procalcitonin and C-Reactive Protein in Patients with Community Acquired Pneumonia and COPD Exacerbation, Iran Red Crescent Med J. 2016 ; 18(12):e25811. doi: 10.5812/ircmj.25811.

Abstract
Copyright © 2016, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Bafadhel M, Clark TW, Reid C, Medina MJ, Batham S, Barer MR, et al. Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD. Chest. 2011; 139(6): 1410-8[DOI][PubMed]
  • 2. Gholamnejad M, Rezaie N. Unusual presentation of chronic eosinophilic pneumonia with "reversed halo sign": a case report. Iran J Radiol. 2014; 11(2): 7891[DOI][PubMed]
  • 3. Burkhardt O, Ewig S, Haagen U, Giersdorf S, Hartmann O, Wegscheider K, et al. Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection. Eur Respir J. 2010; 36(3): 601-7[DOI][PubMed]
  • 4. Habibian S, Mehrabi-Tavana A, Ahmadi Z, Izadi M, Jonaidi N, Darakhshanpoure J, et al. Serotype distribution and antibiotics susceptibility pattern of Streptococcus pneumonia in Iran. Iran Red Crescent Med J. 2013; 15(10): 8053[DOI][PubMed]
  • 5. Javadi Nia S, Zarabi V, Noorbakhsh S, Farhadi M, Ghavidel Darestani S. Chlamydophila pneumoniae Infection Assessment in Children With Adenoid Hypertrophy Concomitant With Rhino Sinusitis. Jundishapur J Microbiol. 2014; 7(8)
  • 6. Dalal AA, Patel J, D'Souza A, Farrelly E, Nagar S, Shah M. Impact of COPD Exacerbation Frequency on Costs for a Managed Care Population. J Manag Care Spec Pharm. 2015; 21(7): 575-83[DOI][PubMed]
  • 7. Taghizadieh A, Rahmani F, Soleimanpour H, Aminifazl H. Comparison of End Tidal Carbon Dioxide and Arterial Blood Bicarbonate Levels in Patients With Exacerbation Chronic Obstructive Pulmonary Disease. Thrita. 2015; 4(2)
  • 8. Daniels JM, Schoorl M, Snijders D, Knol DL, Lutter R, Jansen HM, et al. Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD. Chest. 2010; 138(5): 1108-15[DOI][PubMed]
  • 9. Enguix Armada A, Escobar Conesa R, La Torre AGD, La Torre Prados D, Victoria M. Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin. CCLM. 2015; 54(1): 163-8
  • 10. Liu D, Su L, Han G, Yan P, Xie L. Prognostic Value of Procalcitonin in Adult Patients with Sepsis: A Systematic Review and Meta-Analysis. PLoS One. 2015; 10(6): 129450[DOI][PubMed]
  • 11. Que YA, Guessous I, Dupuis-Lozeron E, Alves de Oliveira CR, Ferreira Oliveir C, Graf R, et al. Prognostication of Mortality in Critically Ill Patients With Severe Infections. Chest. 2015; 148(3): 674-82[DOI][PubMed]
  • 12. Angeletti S, Spoto S, Fogolari M, Cortigiani M, Fioravanti M, De Florio L, et al. Diagnostic and prognostic role of procalcitonin (PCT) and MR-pro-Adrenomedullin (MR-proADM) in bacterial infections. APMIS. 2015; 123(9): 740-8[DOI][PubMed]
  • 13. Fazili T, Endy T, Javaid W, Maskey M. Role of procalcitonin in guiding antibiotic therapy. Am J Health Syst Pharm. 2012; 69(23): 2057-61[DOI][PubMed]
  • 14. Walsh EE, Swinburne AJ, Becker KL, Nylen ES, Snider RH, Baran A, et al. Can serum procalcitonin levels help interpret indeterminate chest radiographs in patients hospitalized with acute respiratory illness? J Hosp Med. 2013; 8(2): 61-7[DOI][PubMed]
  • 15. Moulin F, Raymond J, Lorrot M, Marc E, Coste J, Iniguez JL, et al. Procalcitonin in children admitted to hospital with community acquired pneumonia. Arch Dis Child. 2001; 84(4): 332-6[PubMed]
  • 16. Berg P, Lindhardt BO. The role of procalcitonin in adult patients with community-acquired pneumonia--a systematic review. Dan Med J. 2012; 59(3): 4357[PubMed]
  • 17. Muller B, Harbarth S, Stolz D, Bingisser R, Mueller C, Leuppi J, et al. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis. 2007; 7: 10[DOI][PubMed]
  • 18. Christ-Crain M, Opal SM. Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia. Crit Care. 2010; 14(1): 203[DOI][PubMed]
  • 19. Stolz D, Christ-Crain M, Gencay MM, Bingisser R, Huber PR, Muller B, et al. Diagnostic value of signs, symptoms and laboratory values in lower respiratory tract infection. Swiss Med Wkly. 2006; 136(27-28): 434-40[PubMed]
  • 20. Christ-Crain M, Stolz D, Bingisser R, Muller C, Miedinger D, Huber PR, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med. 2006; 174(1): 84-93[DOI][PubMed]
  • 21. Holm A, Pedersen SS, Nexoe J, Obel N, Nielsen LP, Koldkjaer O. Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care. Br J Gen Pract. 2007; 57(540): 555-60
  • 22. Masia M, Gutierrez F, Shum C, Padilla S, Navarro JC, Flores E, et al. Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index. Chest. 2005; 128(4): 2223-9[DOI][PubMed]
  • 23. Falsey AR, Becker KL, Swinburne AJ, Nylen ES, Snider RH, Formica MA, et al. Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note. Int J Chron Obstruct Pulmon Dis. 2012; 7: 127-35[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments